Virtual Conference

1st EVER

Workforce Management in Manufacturing Symposium

November 17, 11:00am Eastern Standard Time, 2020

Measuring resiliency and benchmarking performance across multiple industries at Canada’s largest turnaround conference.

Discover proven strategies from leading experts to achieve turnaround success in an uncertain market.
Participate in interactive sessions to learn key strategies to managing a team and minimizing costs.
Trade contacts with a multitude of experts during networking sessions.

Join the conference

Lorem ipsum dolor sit

Day(s)

:

Hour(s)

:

Minute(s)

:

Second(s)

March 1st, 2021

11:00-11:10 AM est

Opening remarks

Jean Savage – Vice President, Surface Mining and Technology
11:10-11:40 Am est

State of the Union

Brian Dwyer – Vice President, Manufacturing Operations
Maintaining test agility and resilience within final mile requirements of vaccine distributions
  • Best practices in developing a streamlined, yet resilient, service centered on patient healthcare
  • How to effectively balance agility with speed and efficiency in ensuring final-mile fulfillment
  • Building a supply chain model that’s capable of accommodating emerging threats and volatility created by the ongoing pandemic
  • Exploring Pfizer’s adoption of a responsive, risk-based approach to assimilate and respond to new data that impacts vaccine souring to maintain continuity in dosage deliver to health care providers globally, regionally, and locally
11:40AM-12:10 Pm est

Sponsor Case Study

Scott Gaddis – Vice President, Global Practice Leader – Safety and Health
Securing Stable Supply Chains for Vaccines during the covid-19 crisis and future health emergencies
  • Understanding how inbound logistics and distribution have become major pain points since the onset of the pandemic
  • Taking a proactive rather than reactive approach to developing strategies and structures for vaccine distribution
  • Leveraging Public and Private Sector Collaboration to ensure the successful deployment of the Covid19 Vaccine
  • How DHL can help effectively manage the transport of highly temperature sensitive products to combat further spread of the virtus.
12:10-12:40 pm est

Focus Group Exercise 1

Strategies for Building Resilience into your Cold Chain

FOCUS GROUP LEADERS:

Jean Savage Vice President, Surface Mining and Technology – Caterpillar
Simon KewSenior Vice President, Strategy and Operations – Magna
Simone Frazier Vice President, Manufacturing Development – Keurig Dr. Pepper Inc.
Morten Lundsgaard DegnVice President, Manufacturing & Supply Chain Technology – LEGO Group

Focus Group 1

Focus Group 2

Focus Group 3

Focus Group 4

12:40-1:10 pm est

Panel 1

How Biologics cold chain has evolved in the wake of Covid19 and what that means for the future

Jean Savage Vice President, Surface Mining and Technology – Caterpillar
Simon KewSenior Vice President, Strategy and Operations – Magna
Simone Frazier Vice President, Manufacturing Development – Keurig Dr. Pepper Inc.
Morten Lundsgaard DegnVice President, Manufacturing & Supply Chain Technology – LEGO Group
Scott Gaddis Vice President, Global Practice Leader – Safety and Health, Intelex

  • Understanding the weaknesses in the current cold chain and how those were exposed by the virus
  • Examining the tools, policies, strategies and techniques companies can use to mitigate these risks to ensure life saving drugs end up where they need to be
  • How companies are leveraging this unprecedented crisis to build agility and resilience into their supply chains
  • Preparing for the next crisis, key strategies for building long-term resilience into your biologics supply chain
1:10-1:40 pm est

Afternoon Masterclass

John Sekowski – Vice President, Danaher Business System
Sustaining and Evolving your Culture, Lessons Learned from Danaher
  • Examping the environmental impact of cold chains and looking towards a more sustainable future
  • How the covid19 vaccine has forced companies to rethink their entire cold chain strategy
  • Understanding the different technologies used to ensure cold chain sustainability and how to select the best option for your product
  • Working with different stakeholders in the private and public sector to fix the cold chain to address an crisis arguably larger than Covid19: climate change
1:40-2:10 pm est

Sponsor Case Study

Adam Aguzzi – Vice President, Manufacturing and Value Advisory
Workforace Development Programs As An Engine For Positive Change
  • How cold storage solutions can alleviate some of the challenges related to last mile vaccine distribution
  • Understanding the different storage technologies and how to select the right one for your cold storage needs
  • Leveraging temperature controlled storage solutions to overcome hurdles related to vaccine distribution in hot, remote, or undeveloped regions
  • How Cold Chain Technologies and Moderna have worked together ensure Moderna’s covid19 vaccine services the journey
2:10-2:40 pm est

Focus Group Exercise 2

New and Emerging temperature controlled storage technologies

Jean Savage – Vice President, Surface Mining and Technology – Caterpillar
Simon Kew – Senior Vice President, Strategy and Operations – Magna
Simone Frazier – Vice President, Manufacturing Development – Keurig Dr. Pepper Inc.
Morten Lundsgaard Degn – Vice President, Manufacturing & Supply Chain Technology – LEGO Group

Focus Group 1

Focus Group 2

Focus Group 3

Focus Group 4

2:40-3:10 pm est

Panel 2

Creating an ethical framework for vaccine delivery

Jean Savage Vice President, Surface Mining and Technology – Caterpillar
Simon KewSenior Vice President, Strategy and Operations – Magna
Simone Frazier Vice President, Manufacturing Development – Keurig Dr. Pepper Inc.
Morten Lundsgaard DegnVice President, Manufacturing & Supply Chain Technology – LEGO Group
Adam AguzziVice President, Manufacturing and Value Advisory – Ceridian

  • Understanding the limitations of cold chains and how those limitations have led to unequal distribution of vaccine, especially in remote or undeveloped regions
  • Recognizing the role that biopharmaceutical companies play in promoting the ethical distribution of vaccines
  • Leveraging private/public partnerships to promote faster and more equitable vaccine distribution
  • Exploring how Covid19 provides us with an unprecedented opportunity to overcome traditional barriers to vaccine distribution through the strengthening of cold chains
3:10-3:20 pm est

Closing Remarks

Jean SavageVice President, Surface Mining and Technology
3:20 pm est

Open Networking